Disrupted O-GalNAc glycosylation as a mechanism and biomarker of <i>SLC35A2</i> -associated epilepsy

Rare germline and somatic variants in <i>SLC35A2</i> cause a spectrum of severe glycosylation disorders that commonly present with epilepsy. <i>SLC35A2</i> encodes the Golgi transporter for UDP-galactose, but how its deficiency leads to severe neurodevelopmental disorders is unknown. Using a mouse model deficient for <i>Slc35a2</i> in the forebrain, we identified a specific defect in O-GalNAc glycan synthesis, while other galactose-containing glycoconjugates remained intact. O-GalNAc glycans were absent from their normal location within neuronal tracts of the corpus callosum, and truncated precursors accumulated in the cortex on critical extracellular matrix molecules. Cultured primary neurons lacking <i>Slc35a2</i> showed impaired development, hyperexcitability, and impaired O-GalNAc glycosylation. Finally, human brain tissue from cases of <i>SLC35A2</i> -associated intractable epilepsy displayed a strong correlation between variant burden and truncated O-GalNAc glycans. These findings provide a mechanistic link between genetic causes of <i>SLC35A2</i> -associated epilepsy and protein O-glycosylation that can be targeted for biomarker and therapeutic development.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-03-04
DOI
https://doi.org/10.64898/2026.03.02.708854
Primary Topic
Glycosylation and Glycoproteins Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Disrupted O-GalNAc glycosylation as a mechanism and biomarker of SLC35A2 -associated epilepsy

Savannah Muron, Brianna M. Masters, Daniel C. Koboldt, Richard D. Cummings et al.
bioRxiv (Cold Spring Harbor Laboratory)
Glycosylation and Glycoproteins Research
article

Disrupted O-GalNAc glycosylation as a mechanism and biomarker of SLC35A2 -associated epilepsy

Savannah Muron, Brianna M. Masters, Daniel C. Koboldt, Richard D. Cummings, Julia Furnari, Maxence Noël, Samuel H. Barth, Robert G. Mealer, Amanda Ringland, Adam P. Ostendorf, Christopher R. Pierson, Erin L Heinzen, James J. Anderson, Edward Yang, Alissa M DGama, Kaitlyn DJ Huizar, Annapurna Poduri Poduri, Tracy A Bedrosian, Sheridan L Smith, MaryAnn E Bowyer, Hart GW Lidov, Diana L Thomas, Hyojung Yoon, Sahibjot Sran, Peter D Canoll, Benjamin D Philpot
article en

Abstract

Rare germline and somatic variants in <i>SLC35A2</i> cause a spectrum of severe glycosylation disorders that commonly present with epilepsy. <i>SLC35A2</i> encodes the Golgi transporter for UDP-galactose, but how its deficiency leads to severe neurodevelopmental disorders is unknown. Using a mouse model deficient for <i>Slc35a2</i> in the forebrain, we identified a specific defect in O-GalNAc glycan synthesis, while other galactose-containing glycoconjugates remained intact. O-GalNAc glycans were absent from their normal location within neuronal tracts of the corpus callosum, and truncated precursors accumulated in the cortex on critical extracellular matrix molecules. Cultured primary neurons lacking <i>Slc35a2</i> showed impaired development, hyperexcitability, and impaired O-GalNAc glycosylation. Finally, human brain tissue from cases of <i>SLC35A2</i> -associated intractable epilepsy displayed a strong correlation between variant burden and truncated O-GalNAc glycans. These findings provide a mechanistic link between genetic causes of <i>SLC35A2</i> -associated epilepsy and protein O-glycosylation that can be targeted for biomarker and therapeutic development.

bioRxiv (Cold Spring Harbor Laboratory)
Broad Institute (US), University of North Carolina at Chapel Hill (US), Boston Children's Hospital (US), Nationwide Children's Hospital (US), Beth Israel Deaconess Medical Center (US), Harvard University (US), Columbia University Irving Medical Center (US), Neurological Surgery (US), The Ohio State University (US), Columbia University (US)
Good health and well-being
Openalex Percentile: Top 34%
Glycosylation and Glycoproteins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.